BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20876772)

  • 41. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
    Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
    Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The applications of anti-CD20 antibodies to treat various B cells disorders.
    Payandeh Z; Bahrami AA; Hoseinpoor R; Mortazavi Y; Rajabibazl M; Rahimpour A; Taromchi AH; Khalil S
    Biomed Pharmacother; 2019 Jan; 109():2415-2426. PubMed ID: 30551501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.
    Kyaw T; Tay C; Khan A; Dumouchel V; Cao A; To K; Kehry M; Dunn R; Agrotis A; Tipping P; Bobik A; Toh BH
    J Immunol; 2010 Oct; 185(7):4410-9. PubMed ID: 20817865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-P. gingivalis response correlates with atherosclerosis.
    Ford PJ; Gemmell E; Timms P; Chan A; Preston FM; Seymour GJ
    J Dent Res; 2007 Jan; 86(1):35-40. PubMed ID: 17189460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo.
    Oscherwitz J; Gribbin TE; Cease KB
    Mol Immunol; 2010 Apr; 47(7-8):1484-91. PubMed ID: 20189250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic effects of the trifunctional bispecific antibody FBTA05 in ex-vivo cells of chronic lymphocytic leukaemia depend on immune-mediated mechanism.
    Boehrer S; Schroeder P; Mueller T; Atz J; Chow KU
    Anticancer Drugs; 2011 Jul; 22(6):519-30. PubMed ID: 21637160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
    Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
    Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.
    Johnson-Léger C; Hasbold J; Holman M; Klaus GG
    J Immunol; 1997 Aug; 159(3):1150-9. PubMed ID: 9233608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
    Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
    PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cell responses to a peptide epitope. IX. The kinetics of antigen binding differentially regulates costimulatory capacity of activated B cells.
    Vijayakrishnan L; Natarajan K; Manivel V; Raisuddin S; Rao KV
    J Immunol; 2000 Jun; 164(11):5605-14. PubMed ID: 10820235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-Cell/B-Cell Interactions in Atherosclerosis.
    Jones PW; Mallat Z; Nus M
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1502-1511. PubMed ID: 38813700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.
    Tsokos GC
    N Engl J Med; 2004 Jun; 350(25):2546-8. PubMed ID: 15201410
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
    Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice.
    Moos MP; John N; Gräbner R; Nossmann S; Günther B; Vollandt R; Funk CD; Kaiser B; Habenicht AJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2386-91. PubMed ID: 16179593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.
    Ma K; Lv S; Liu B; Liu Z; Luo Y; Kong W; Xu Q; Feng J; Wang X
    Cardiovasc Res; 2013 Feb; 97(2):349-59. PubMed ID: 23118130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice.
    Sultan A; Strodthoff D; Robertson AK; Paulsson-Berne G; Fauconnier J; Parini P; Rydén M; Thierry-Mieg N; Johansson ME; Chibalin AV; Zierath JR; Arner P; Hansson GK
    Circ Res; 2009 Apr; 104(8):961-8. PubMed ID: 19299644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.
    Wijesuriya R; Maruo S; Zou JP; Ogawa M; Umehara K; Yamashita M; Ono S; Fujiwara H; Hamaoka T
    Int Immunol; 1998 Aug; 10(8):1057-65. PubMed ID: 9723691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Mouse Models in Atherosclerosis Research.
    Getz GS; Reardon CA
    Methods Mol Biol; 2015; 1339():1-16. PubMed ID: 26445778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.
    Soh SY; Faveeuw C; Thiam CH; Khoo LH; Yeo KP; Lim SY; Lim HY; Ng JX; Angeli V
    J Immunol; 2016 Nov; 197(10):3894-3904. PubMed ID: 27798147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
    Takasaki Y
    Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.